Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Minority Interest: 2018-2021

Historic Minority Interest for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Jun 2021 value amounting to $45.2 million.

  • Amphastar Pharmaceuticals' Minority Interest rose 1.06% to $45.2 million in Q2 2021 from the same period last year, while for Jun 2021 it was $45.2 million, marking a year-over-year increase of 1.06%. This contributed to the annual value of $46.4 million for FY2020, which is 0.55% up from last year.
  • As of Q2 2021, Amphastar Pharmaceuticals' Minority Interest stood at $45.2 million, which was down 0.38% from $45.4 million recorded in Q1 2021.
  • Amphastar Pharmaceuticals' 5-year Minority Interest high stood at $46.4 million for Q4 2020, and its period low was $21.9 million during Q3 2018.
  • Moreover, its 3-year median value for Minority Interest was $45.3 million (2019), whereas its average is $45.4 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Minority Interest surged by 102.47% in 2019 and then declined by 1.00% in 2021.
  • Quarterly analysis of 4 years shows Amphastar Pharmaceuticals' Minority Interest stood at $31.9 million in 2018, then soared by 44.60% to $46.2 million in 2019, then climbed by 0.55% to $46.4 million in 2020, then climbed by 1.06% to $45.2 million in 2021.
  • Its Minority Interest stands at $45.2 million for Q2 2021, versus $45.4 million for Q1 2021 and $46.4 million for Q4 2020.